---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

secured: "5hxpH4ormS3ulnwamrGx4Ih2wvj9jmLsPA7UYV3bBkxf26sEHxnMHTNQGJiklJzFfM5/159EotaSO615u1nWT+l1u06Y3Y+Cb65a1HJqSo0+CVBh0ZWTEPS30V3pe32E5A/E+EZxRTUVYXkexXAwoNyQtPn+O9FLCBzjVG9hUATOjQCBg5SHsn7u5By127zA5t/8STDj5zRtvKsNv+r30SgAjJheT8c0FHBadFqYpeqVszevtAWVokNBIHIB1LaBUD1s46KwOrBiAlQID4VZKnL/Q2XwNXUsFMiiOvdMSuS3oikw/GBAC/TVR0FmLgkE;774eKPkZkJq8weUfm6553A=="
---

